Elucidating the exact pharmacological mechanism of action (MOA) of naturally happening compounds can be challenging. While Tarselli et al. (60) developed the main de novo artificial pathway to conolidine and showcased this naturally transpiring compound proficiently suppresses responses to both chemically induced and inflammation-derived pain, the pharmacologic target accountable https://alicea219zab0.wikitelevisions.com/user